Protocol for randomized controlled trial to evaluate the safety and feasibility of a novel helmet to deliver transcranial light emitting diodes photobiomodulation therapy to patients with Parkinson’s disease

INTRODUCTION: Parkinson’s disease (PD) is the second most common, progressive, and debilitating neurodegenerative disease associated with aging and the most common movement disorder. Photobiomodulation (PBM), the use of non-thermal light for therapeutic purposes using laser or light emitting diodes...

Descripción completa

Detalles Bibliográficos
Autores principales: McGee, Claire, Liebert, Ann, Herkes, Geoffrey, Bicknell, Brian, Pang, Vincent, McLachlan, Craig S., Kiat, Hosen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428720/
https://www.ncbi.nlm.nih.gov/pubmed/36061601
http://dx.doi.org/10.3389/fnins.2022.945796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428720/
https://www.ncbi.nlm.nih.gov/pubmed/36061601
http://dx.doi.org/10.3389/fnins.2022.945796

Ejemplares similares